PhaseRx signs technology evaluation agreement with Monsanto

PhaseRx, Inc., a privately held RNAi delivery technology company, announced that it has signed a funded technology evaluation agreement with Monsanto Company for PhaseRx's delivery technologies. Through the agreement, Monsanto will evaluate PhaseRx's SMARTT Polymer Technology for potential agricultural applications. Terms of the agreement were not disclosed.

"This agreement with Monsanto represents PhaseRx's first project in the large and growing field of agriculture," said Robert Overell, Ph.D., president and chief executive officer of PhaseRx, Inc. "It also helps further validate the breadth of PhaseRx platform capabilities beyond our primary focus applications."

Comments (0) Leave a comment